Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: With or without imatinib in chemotherapy

Annals of Hematology

Volumn 88, Issue 11, 2009, Pages 1069-1077

  Li, Yenan ^a   Qiu, Lugui ^a   Zou, Dehui ^a   Zhao, Yaozhong ^a   Mi, Yingchang ^a   Wang, Jianxiang ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Acute lymphoblastic leukemia; Additional aberrations; Imatinib; Karyotype; Philadelphia chromosome

Indexed keywords

ASPARAGINASE; ASPARAGINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; IMATINIB; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISONE; VINCRISTINE; VINDESINE; ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; PIPERAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM LEUKEMIA; CHINESE; CHROMOSOME 14; CHROMOSOME 18; CHROMOSOME 21; CHROMOSOME 7; CHROMOSOME 7P; CHROMOSOME 9; CHROMOSOME 9P; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; METAPHASE; OVERALL SURVIVAL; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; TRISOMY; COMPARATIVE STUDY; DRUG ANTAGONISM; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PATHOLOGY; SALVAGE THERAPY;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHROMOSOME ABERRATIONS; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; FUSION PROTEINS, BCR-ABL; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; METHOTREXATE; MIDDLE AGED; MITOXANTRONE; PIPERAZINES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PREDNISONE; PROGNOSIS; PYRIMIDINES; SALVAGE THERAPY; VINCRISTINE; VINDESINE; YOUNG ADULT;

EID: 70349435047     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0720-z     Document Type: Article

References (27)

1. Faderl S, Kantarjian HM, Talpaz M, Estrov Z (1998) Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukemia. Blood 91:3995-4019
2. Larson RA (2006) Management of acute lymphoblastic leukemia in older patients. Semin Hematol 43:126-133. doi: 10.1053/ j.seminhematol.2006.01.007
3. Rieder H, Ludwig W-D, Gassmann W et al (1996) Prognostic significance of additional chromosome abnormalities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia. Br J Haematol 95:678-691. doi: 10.1046/j.1365-2141.1996.d01-1968.x
4. Groupe Francais de Cytogenetique Hematologique (1996) Cytogenetic abnormalities in adult acute lymphoblastic leukemia: Correlations with hematologic findings and outcome. A collaborative study of the Groupe Francais de Cytogenetique Hematologique. Blood 87:3135-3142
5. Crist WM, Carroll AJ, Jackson JF et al (1990) Philadelphia chromosome positive childhood acute lymphoblastic leukemia: Clinical and cytogenetic characteristics and treatment outcome. A Pediatric Oncology Group study. Blood 76:489-494
6. Gotz G, Weh H-J, Walter TA et al (1992) Clinical and prognostic significance of Philadelphia chromosome in adult patients with acute lymphoblastic leukemia. Ann Hematol 64:97-100. doi: 10.1007/BF01715353
7. Johansson B, Mertens F, Mitelman F (1994) Secondary chromosomal abnormalities in acute leukemia. Leukemia 8:953-962
8. Heerema NA, Harbott J, Galimberti S et al (2004) Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome. Leukemia 18(4):693-702. doi: 10.1038/sj.leu.2403324
9. Wetzler M, Dodge RK, Mrózek K et al (2004) Additional cytogenetic abnormalities in adults with Philadelphia chromosome-positive acute lymphoblastic leukaemia: A study of the Cancer and Leukaemia Group B. Br J Haematol 124(3):275-288. doi: 10.1046/j.1365-2141.2003.04736.x
10. Yanada M, Takeuchi J, Sugiura I et al (2008) Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy. Haematologica 93(2):287-290. doi: 10.3324/haematol.11891
11. Ko BS, Tang JL, Lee FY et al (2002) Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/ BCR-ABL-positive acute lymphoblastic leukemia in Taiwan. Am J Hematol 71(4):291-299. doi: 10.1002/ajh.10227
12. Moorman AV, Harrison CJ, Buck GA et al (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): Analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 109(8):3189-3197. doi: 10.1182/ blood-2006-10-051912
13. Trueworthy R, Shuster J, Look M et al (1992) Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: A Pediatric Oncology Group study. J Clin Oncol 10:606-613
14. Tien HF, Wang CH, Lin MT et al (1995) Correlation of cytogenetic results with immunophenotype, genotype, clinical features and ras-mutation in acute myeloid leukemia. Cancer Genet Cytogenet 84:60-68. doi: 10.1016/ 0165-4608(95) 00084-4
15. Johansson B, Mertenes F, Mitelman F (1990) Geographic heterogeneity of neoplasm-associated chromosome aberrations. Genes Chromosomes Cancer 3:1-7. doi: 10.1002/gcc.2870030102
16. Yanada M, Takeuchi J, Sugiura I et al (2006) High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL positive acute lymphoblastic leukemia: A phase II study by the Japan Adult Leukemia Study Group. J Clin Oncol 24(3):460-466. doi: 10.1200/JCO.2005.03.2177
17. Thomas DA, Faderl S, Cortes J et al (2005) Outcome with the hyper-CVAD and imatinib mesylate regimen in Philadelphia (Ph) positive acute lymphocytic leukemia (ALL). Blood 106:1830 abstract
18. Ribera JM, Oriol A, Gonzalez M et al (2004) Treatment of Philadelphia chromosome (Ph)-positive acute lymphoblastic leukemia (ALL) with concurrent chemotherapy and imatinib mesylate. Blood 104:4483 abstract
19. Vignetti M, Fazi P, Cimino G et al (2007) Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: Results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. Blood 109(9):3676-3678. doi: 10.1182/blood-2006-10-052746
20. Wassmann B, Pfeifer H, Goekbuget N et al (2006) Alternating versus concurrent schedules of imatinib and chemotherapy as front-line therapy for Philadelphia-positive acute lymphoblastic leukemia (Ph-positive ALL). Blood 108(5):1469-1477. doi: 10.1182/blood-2005-11-4386
21. Johansson B, Fioretos T, Mitelman F (2002) Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107(2):76-94. doi: 10.1159/000046636
22. Faderl S, Kantarjian HM, Thomas DA et al (2000) Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia. Leuk Lymphoma 36(3-4):263-273. doi: 10.3109/10428190009148847
23. Thomas X, Thiebaut A, Olteanu N et al (1998) Philadelphia chromosome positive adult acute lymphoblastic leukemia: Characteristics, prognostic factors and treatment outcome. Hematol Cell Ther 40(3):119-128
24. Russo C, Carroll A, Kohler S et al (1991) Philadelphia chromosome and monosomy 7 in childhood acute lymphoblastic leukemia: A Pediatric Oncology Group study. Blood 77:1050-1056
25. Heerema NA, Nachman JB, Sather HN et al (2004) Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: A report from the Children's Cancer Group. Leukemia 18(5):939-947. doi: 10.1038/sj.leu.2403327
26. Buysse K, Crepel A, Menten B et al (2008) Mapping of 5q35 chromosomal rearrangements within a genomically unstable region. J Med Genet 45(10):672-678. doi: 10.1136/jmg.2008.058883
27. Faderl S, Gidel C, Kantarjian HM et al (2001) Loss of heterozygosity on chromosome 5 in adults with acute lymphoblastic leukemia. Leuk Res 25(1):39-43. doi: 10.1016/S0145-2126(00) 00084-9